Get the app
US › Healthcare

ABVC Biopharma Inc (ABVC)

US · Healthcare · Biotechnology

$0.92-1.61%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-736,934
EPS
$-0.03

Key statistics

Market cap
$24.7M
Forward P/E
0.0
P/B
2.95
Book value
$0.40
EPS (TTM)
$-0.30
52-week high
$3.07
52-week low
$0.71
50-day MA
$0.98
200-day MA
$1.32
Beta
0.51

Analyst view

with an average price target of $2.02.

Shareholding

Insiders
18.09%
Institutions
4.08%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC1.40%
Geode Capital Management, LLC0.85%
Vanguard Fiduciary Trust Co0.36%
State Street Corp0.27%
Citadel Advisors Llc0.27%
BlackRock Inc0.21%
Northern Trust Corp0.18%
XTX Topco Ltd0.18%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ABVC Biopharma Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.